Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 18,600 shares, an increase of 500.0% from the October 31st total of 3,100 shares. Based on an average daily volume of 116,500 shares, the days-to-cover ratio is presently 0.2 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group upgraded Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th.
Get Our Latest Analysis on Lonza Group
Lonza Group Stock Down 2.1 %
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Recommended Stories
- Five stocks we like better than Lonza Group
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Evaluate a Stock Before BuyingÂ
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Insider Buying Explained: What Investors Need to Know
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.